Frisch Medical Device Private Limited
Clinical trials sponsored by Frisch Medical Device Private Limited, explained in plain language.
-
New heart stent shows promise in 888-Patient trial
Disease control CompletedThis study tested a new drug-coated stent called EvroSure in 888 people with blocked heart arteries. The stent slowly releases medicine to keep the artery open. Researchers tracked heart-related events like heart attacks and repeat procedures for up to 12 months to see if the ste…
Phase: PHASE4 • Sponsor: Frisch Medical Device Private Limited • Aim: Disease control
Last updated May 12, 2026 13:41 UTC
-
New balloon treatment aims to keep heart arteries open
Disease control CompletedThis study tested a special balloon coated with sirolimus, a drug that helps prevent arteries from narrowing again. It involved 360 adults with coronary artery disease who needed a procedure to open blocked heart vessels. The main goal was to see if the balloon reduces major hear…
Phase: PHASE4 • Sponsor: Frisch Medical Device Private Limited • Aim: Disease control
Last updated May 08, 2026 12:01 UTC